Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice-Reference-Cited by-同舟云学术

Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice

Published:2023-01-24 Issue:5 Volume:117 Page:718-728
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Mizuguchi Makiko,Okamoto Yasunobu,Yagi Hikaru,Kagawa Kumiko,Sekimoto Etsuko,Shibata Hironobu,Shigekiyo Toshio,Ozaki Shuji^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-023-03541-x.pdf

Reference51 articles.

1. van de Donk N, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397:410–27.

2. Avet-Loiseau H, Durie BG, Cavo M, Attal M, Gutierrez N, Haessler J, et al. Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an international myeloma working group collaborative project. Leukemia. 2013;27:711–7.

3. Manier S, Salem KZ, Park J, Landau DA, Getz G, Ghobrial IM. Genomic complexity of multiple myeloma and its clinical implications. Nat Rev Clin Oncol. 2017;14:100–13.

4. Shah V, Sherborne AL, Walker BA, Johnson DC, Boyle EM, Ellis S, et al. Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. Leukemia. 2018;32:102–10.

5. Davies FE, Pawlyn C, Usmani SZ, San-Miguel JF, Einsele H, Boyle EM, et al. Perspectives on the risk-stratified treatment of multiple myeloma. Blood Cancer Discov. 2022;3:273–84.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG);Leukemia & Lymphoma;2024-08-14

2. Performance of newer myeloma staging systems in a contemporary, large patient cohort;Blood Cancer Journal;2024-06-11

3. Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS;Blood Advances;2023-11-01